this post was submitted on 17 Jul 2023
146 points (99.3% liked)

Technology

73876 readers
3596 users here now

This is a most excellent place for technology news and articles.

Our Rules

  1. Follow the lemmy.world rules.
  2. Only tech related news or articles.
  3. Be excellent to each other!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, this includes using AI responses and summaries. To ask if your bot can be added please contact a mod.
  9. Check for duplicates before posting, duplicates may be removed
  10. Accounts 7 days and younger will have their posts automatically removed.

Approved Bots

founded 2 years ago
MODERATORS
L3s@lemmy.world
enu@lemmy.world
technopagan@lemmy.world
L4s@lemmy.world
L3s@hackingne.ws
L4s@hackingne.ws
146
Eli Lilly drug shown to slow Alzheimer’s progression (arstechnica.com)
submitted 2 years ago by PopBobert@lemmy.world to c/technology@lemmy.world
10 comments fedilink hide all child comments
 

Dementia experts hail "watershed moment" after trial results for donanemab antibody treatment.

you are viewing a single comment's thread
view the rest of the comments
[–] dedale@kbin.social 11 points 2 years ago* (last edited 2 years ago)

Very skeptical of that one.
They've been trying to target amyloid for more than a decade, and it's the first time I hear of it actually working.

The treatment seem to have huge side effects (brain bleeding and swelling) and lead to patient death during the study.
Elly Lilly is also know for marketing zyprexa as a treatment for dementia (despite inefficacy and increased risk of death). Which is IMO criminal, at best unethical. I'm not inclined to trust them at all.

I hope I'm wrong and it works. Alzheimer is a terrible way to go.